Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study will examine the activity of PF-05089771 and pregabalin, alone and in combination
on a panel of evoked pain tests carried out from 0.5 to 10 hours following oral dosing in
healthy male subjects